Protocol for a cluster randomised trial in Madhya Pradesh, India: community health promotion and medical provision and impact on neonates (CHAMPION2); and support to rural India's public education system and impact on numeracy and literacy scores (STRIPES2).


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
25 Jun 2020
Historique:
received: 06 01 2020
accepted: 23 04 2020
entrez: 27 6 2020
pubmed: 27 6 2020
medline: 7 4 2021
Statut: epublish

Résumé

Rural areas of India exhibit high neonatal mortality, and low literacy and numeracy. We assess the effect of a complex package of health interventions on neonatal survival and the effect of out-of-school-hours teaching on children's literacy and numeracy in rural Madhya Pradesh. This is a cluster-randomised controlled trial with villages (clusters) receiving either a health (CHAMPION2) or education (STRIPES2) intervention. Building on the design of the earlier CHAMPION/STRIPES trial, villages receiving the health intervention are controls for the education intervention and vice versa. The clusters are 196 villages in Satna district, Madhya Pradesh, India: each is at least 5 km from a Community Health Centre, has a population below 2500, and has at least 15 children eligible for the education intervention. The participants in CHAMPION2 are resident married women younger than 50 years of age who had not undergone a family planning operation, provided they are enumerated pre-randomisation or marry a man enumerated pre-randomisation. The participants in STRIPES2 are resident children born 16 June 2010 to 15 June 2013, not in school before the 2018-2019 school year and intending to enrol in first grade in 2018-2019 or 2019-2020. In CHAMPION2, the NICE Foundation will deliver a 3.5-year programme comprising Accredited Social Health Activists or village health workers and midwives promoting health knowledge and providing antenatal, postnatal, and neonatal healthcare; community mobilisation; referrals to appropriate government health facilities; and a health education campaign. In STRIPES2, the Pratham Education Foundation will deliver a programme of village-based, before/after school support focusing on literacy and numeracy. As controls, the CHAMPION2 control villages will receive the usual health services (plus the STRIPES2 intervention). STRIPES2 control villages will receive the usual education services (plus the CHAMPION2 intervention). The primary outcome in CHAMPION2 is neonatal mortality. Secondary outcomes include antenatal, delivery, immediate neonatal and postnatal care practices, maternal mortality, stillbirths, early neonatal deaths, perinatal deaths, health knowledge, hospital admissions, maternal blood transfusions, and cost effectiveness. The primary outcome in STRIPES2 is a composite literacy and numeracy test score. Secondary outcomes include separate literacy and numeracy scores, reported school enrolment and attendance, parents' engagement with children's learning, and cost effectiveness. Independent research and implementation teams will conduct the trial. Trial Steering and Data Monitoring Committees, with independent members, will supervise the trial. Clinical Trial Registry of India: CTRI/2019/05/019296. Registered on 23 May 2019. http://www.ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=31198&EncHid=&modid=&compid=%27,%2731198det%27.

Sections du résumé

BACKGROUND BACKGROUND
Rural areas of India exhibit high neonatal mortality, and low literacy and numeracy. We assess the effect of a complex package of health interventions on neonatal survival and the effect of out-of-school-hours teaching on children's literacy and numeracy in rural Madhya Pradesh.
METHODS/DESIGN METHODS
This is a cluster-randomised controlled trial with villages (clusters) receiving either a health (CHAMPION2) or education (STRIPES2) intervention. Building on the design of the earlier CHAMPION/STRIPES trial, villages receiving the health intervention are controls for the education intervention and vice versa. The clusters are 196 villages in Satna district, Madhya Pradesh, India: each is at least 5 km from a Community Health Centre, has a population below 2500, and has at least 15 children eligible for the education intervention. The participants in CHAMPION2 are resident married women younger than 50 years of age who had not undergone a family planning operation, provided they are enumerated pre-randomisation or marry a man enumerated pre-randomisation. The participants in STRIPES2 are resident children born 16 June 2010 to 15 June 2013, not in school before the 2018-2019 school year and intending to enrol in first grade in 2018-2019 or 2019-2020.
DISCUSSION CONCLUSIONS
In CHAMPION2, the NICE Foundation will deliver a 3.5-year programme comprising Accredited Social Health Activists or village health workers and midwives promoting health knowledge and providing antenatal, postnatal, and neonatal healthcare; community mobilisation; referrals to appropriate government health facilities; and a health education campaign. In STRIPES2, the Pratham Education Foundation will deliver a programme of village-based, before/after school support focusing on literacy and numeracy. As controls, the CHAMPION2 control villages will receive the usual health services (plus the STRIPES2 intervention). STRIPES2 control villages will receive the usual education services (plus the CHAMPION2 intervention). The primary outcome in CHAMPION2 is neonatal mortality. Secondary outcomes include antenatal, delivery, immediate neonatal and postnatal care practices, maternal mortality, stillbirths, early neonatal deaths, perinatal deaths, health knowledge, hospital admissions, maternal blood transfusions, and cost effectiveness. The primary outcome in STRIPES2 is a composite literacy and numeracy test score. Secondary outcomes include separate literacy and numeracy scores, reported school enrolment and attendance, parents' engagement with children's learning, and cost effectiveness. Independent research and implementation teams will conduct the trial. Trial Steering and Data Monitoring Committees, with independent members, will supervise the trial.
TRIAL REGISTRATION BACKGROUND
Clinical Trial Registry of India: CTRI/2019/05/019296. Registered on 23 May 2019. http://www.ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=31198&EncHid=&modid=&compid=%27,%2731198det%27.

Identifiants

pubmed: 32586400
doi: 10.1186/s13063-020-04339-6
pii: 10.1186/s13063-020-04339-6
pmc: PMC7318373
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

569

Subventions

Organisme : Effective Intervention
ID : not applicable

Références

PLoS Med. 2012;9(11):e1001346
pubmed: 23185138
Reprod Health. 2014 Jul 22;11:57
pubmed: 25048795
PLoS One. 2013 Jul 16;8(7):e65775
pubmed: 23874383
Lancet. 2013 May 18;381(9879):1736-46
pubmed: 23683640
BMC Pregnancy Childbirth. 2014 May 24;14:174
pubmed: 24885817
Lancet Glob Health. 2019 Jun;7(6):e721-e734
pubmed: 31097276
BMC Pediatr. 2007 Jul 12;7:26
pubmed: 17625023
BMJ. 2012 Sep 04;345:e5661
pubmed: 22951546
Lancet Glob Health. 2016 Feb;4(2):e119-28
pubmed: 26823213
Lancet. 2016 Feb 6;387(10018):587-603
pubmed: 26794078
Br J Cancer. 1977 Jan;35(1):1-39
pubmed: 831755
Lancet. 2008 Sep 27;372(9644):1151-62
pubmed: 18926277
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Cochrane Database Syst Rev. 2015 Mar 23;(3):CD007754
pubmed: 25803792
PLoS One. 2014 May 14;9(5):e96287
pubmed: 24828520
BMJ. 2012 Mar 21;344:e1634
pubmed: 22438367
Int J Gynaecol Obstet. 2005 Feb;88(2):181-93
pubmed: 15694106
J Perinatol. 2005 Mar;25 Suppl 1:S92-107
pubmed: 15791283
Lancet. 2010 Jun 5;375(9730):2009-23
pubmed: 20569841
BMC Pregnancy Childbirth. 2016 May 18;16(1):116
pubmed: 27193837

Auteurs

Arjun Agarwal (A)

Pratham Education Foundation, New Delhi, India.

Rukmini Banerji (R)

Pratham Education Foundation, New Delhi, India.

Peter Boone (P)

Effective Intervention, London, UK.

Diana Elbourne (D)

London School of Hygiene and Tropical Medicine, London, UK.

Ila Fazzio (I)

Effective Intervention, London, UK. if@effint.org.

Chris Frost (C)

London School of Hygiene and Tropical Medicine, London, UK.

Madan Gopal (M)

NICE Foundation, Hyderabad, India.

Sridevi Karnati (S)

GH Training and Consulting, Hyderabad, India.

Rakhi Nair (R)

NICE Foundation, Hyderabad, India.

Harshavardhan Reddy (H)

GH Training and Consulting, Hyderabad, India.

Padmanabh Reddy (P)

NICE Foundation, Hyderabad, India.

Dropti Sharma (D)

Pratham Education Foundation, New Delhi, India.

Sajjan Singh Shekhawat (SS)

Pratham Education Foundation, New Delhi, India.

Siddharudha Shivalli (S)

London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH